Announcement: Study Milestone licensing contract signed between MEDIAPHARMA and INVENT

Prof. Stefano Iacobelli


We are proud to announce that MEDIAPHARMA led by Prof. Stefano Iacobelli and participated by INVENT (INNOVA seed capital fund) has just signed a Study Milestone licensing contract for a  patented oncological antibody to a leading international Big Pharma which will also entitle to exercise a right of first negotiation to pursue any additional Antibodies conceived. The terms of the agreement are confidential and foresee milestones achievements up to over 26M US$.

Keep in touch for further update on this study milestone.



© Copyright INNOVA

Privacy Policy

Legal Note